Cetirizine Hydrochloride + Phenylephrine Hydrochloride + ParacetamolThird Party Manufacturing in India

This triple fixed-dose combination provides comprehensive symptomatic relief for the common cold and allergic rhinitis by targeting three distinct symptom pathways simultaneously.

Cetirizine Hydrochloride is a second-generation antihistamine that selectively blocks peripheral H1 histamine receptors. By preventing histamine from binding to its receptors on vascular endothelium and immune cells, it suppresses sneezing, rhinorrhea, nasal itching, and ocular symptoms. Its reduced penetration across the blood-brain barrier makes it less sedating than older antihistamines.

Phenylephrine Hydrochloride is a selective alpha-1 adrenergic receptor agonist. It constricts the capacitance blood vessels in the nasal mucosa, reducing blood volume in the inflamed tissues and shrinking swollen mucous membranes. This provides rapid decongestion, opening blocked nasal passages and restoring normal breathing.

Paracetamol (Acetaminophen) exerts its analgesic and antipyretic effects primarily through central mechanisms. It is metabolized in the liver to p-aminophenol, which crosses the blood-brain barrier and is converted by fatty acid amide hydrolase into AM404, a bioactive metabolite. AM404 activates TRPV1 receptors in the brain and dorsal horn, triggering a signaling cascade that modulates descending serotonergic pain pathways. This produces effective analgesia without the peripheral anti-inflammatory effects or gastrointestinal side effects associated with NSAIDs. Paracetamol also inhibits central COX enzymes in areas with low peroxide tone, contributing to its antipyretic action.

This triple combination is prescribed for the treatment of:

• Common Cold: Provides comprehensive relief from the full spectrum of cold symptoms including fever, headache, body aches, nasal congestion, sneezing, and runny nose.
• Allergic Rhinitis with Fever: Used when allergic rhinitis is accompanied by fever or general malaise.
• Sinusitis with Headache: Relieves sinus congestion, pressure, headache, and associated allergic symptoms.
• Upper Respiratory Tract Infections: Provides symptomatic support during viral respiratory infections presenting with congestion, fever, and allergic-type symptoms.

Why Manufacturers Choose This Combination

This three-drug combination is one of the highest-volume over-the-counter cold and flu products in the Indian pharmaceutical market. The synergy of antihistamine, decongestant, and analgesic in a single tablet offers patients convenience and ensures compliance. It is a preferred recommendation by pharmacists and general practitioners for acute upper respiratory infections. Indian manufacturers have robust production capabilities for this combination, with well-established supply chains for all three APIs. The export demand, particularly to Asia, Africa, and the Middle East, remains consistently strong.

This makes the Cetirizine + Phenylephrine + Paracetamol combination one of the most consistently demanded products for third party manufacturing in India, with high-volume turnover across both domestic PCD networks and international markets.